Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 28, 1998 - Issue 1
186
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and metabolism of darifenacin in the mouse, rat, dog and man

, , &
Pages 63-75 | Published online: 22 Sep 2008

References

  • FRANZ, P.M., MATTIUZ, E. L., HATCHER, B. L., DESANTE, K. A., BREAU, A. P., OCCOLOWITZ, J. L., DORMAN, D. E., SCHMID, C. R., GOLDBERG, M . J. and RusiN, A.,1993,Dispositionof Zatosetron, a serotonin receptor antagonist, in hum ans. Drug Metabolism and Disposition, 21, 249–254.
  • JOHN, BA., CHASSEAUD, L. F., WOOD S. G. and FORLOT, P., 1992, Metabolism of the anti-psoratic agent 5 -methoxypsoralen in humans: comparison with rat and dog. Xenobiotka 22, 1339–1351.
  • KAYE, B., HERRON, W. J., MACRAE, P. V., ROBINSON, S., STOPHER, D. A., VENN, R. F. and WILD, W 1996, Rapid, solid phase extraction technique for the high-throughput assay of darifenacin in human plasma. Analytical Chemistry, 68, 1658–1660.
  • MAYS, D. C., ROGERS, S. L., GUILER, R. C., SHARP, D. E., HECHT, S. G., STAUBUS, A. E. and GERBER, N., 1986, Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites. Journal of Pharmacology and Experimental Therapeutics, 236, 364–373.
  • NEWGREEN, D. T. and NAYLOR, A. M., 1996, Characterisation of functional muscarinic receptors in human bladder. British Journal of Pharmacology, 119, 45P.
  • NORDHOLM, L., WASSMANN, 0., NEILSEN, P., THOEGERSEN, H. and GROENVALD, F., 1992, Identification of the major metabolites of [31-1]-(+ )-8-chloro -5 -(2,3-dihydrobenzfuran-7-y1)-7-m ethoxy-methyloxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine in rats. Xenobiotka, 23, 345.
  • QUINN, P., MCINTYRE, P., MINER, W. D. and WALLIS, R. M., 1996, In vivo profile of darifenacin, a selective muscarinic M3 receptor antagonist. British Journal of Pharmacology, 119, 198P.
  • SMITH, D. A.,1991,Aromatichydroxylationof arylalkylaminesin rodents. Drug Metabolism Reviews, 23, 355–373.
  • SOUDIJN, W., VAN WINJNGAARDEN, I. and ALLEWUN, F., 1967, D istribution, excretion and metabolism of neroleptics of the butyrophenone type. European Journal of Pharmacology, 1,47-57. WALLIS, R. M., BURGES, R. A., CROSS, P. E., MACKENZIE, A. R., NEWGREEN, D. T. and QuINN, P.,1995, D arifenacin, a selective muscarinic M3 antagonist. Pharmacological Research, 31S, 54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.